Track market-moving stories before they get noisy

SEATTLE--(BUSINESS WIRE)--U.S. pending home sales fell 1.3% week over week to their lowest level in three months during the four weeks ending July 19. That's according to a new report from Redfin, the real estate brokerage powered by Rocket. The decline in homebuying demand comes as weekly average mortgage rates rise to a 11-month high of 6.55%. Additionally, home prices are stubbornly high, sitting just about $900 shy of their all-time peak. The topsy turvy U.S. economy, including the resurgen.

Saudi Arabian oil company Aramco's logo during the CERAWeek energy conference 2026 in Houston, Texas, U.S., March 24, 2026. REUTERS/Danielle Villasana Purchase Licensing Rights, opens new tab

CompaniesLONDON, July 23 (Reuters) - Saudi Aramco has offered additional crude cargoes ​for loading from Egypt's Mediterranean ‌port of Sidi Kerir, according to five trading sources, signalling ​a potential shift in ​export routes as Houthi threats ⁠to shipping raise risks ​for oil movements through the ​Red Sea and the Bab el-Mandeb strait.

The cargoes are being offered on ​a spot basis, two ​of the sources said, supplementing supplies ‌to ⁠Aramco's term buyers. While Aramco already supplies some customers in Europe and North America ​from Sidi ​Kerir, ⁠the additional volumes suggest the Saudi producer ​is seeking greater flexibility ​in ⁠reaching its markets as security risks persist along the ⁠Red ​Sea route.

The Reuters Power Up newsletter provides everything you need to know about the global energy industry. Sign up here.

Aramco declined ​to comment.

Reporting by Ahmad Ghaddar and Robert ​Harvey, Editing by Louise Heavens

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Philip Morris International Today

PM

Philip Morris International

$192.66 -1.64 (-0.85%)

As of 10:00 AM Eastern

This is a fair market value price provided by Massive. Learn more.

52-Week Range$142.11▼

$199.78Dividend Yield3.05%

P/E Ratio26.99

Price Target$201.44

The economy isn’t the stock market, but there are times when the two align. That's one way to look at Philip Morris' NYSE: PM Q2 2026 earnings report. The company delivered a beat on revenue and earnings, driven by strength in its smoke-free business and better-than-expected performance in its legacy nicotine products.

This shouldn’t be a surprise in an uneven economy. Philip Morris sells nicotine products in a category where demand has historically remained resilient, even when consumers are under pressure.

Get PM alerts:

PM climbed after the report, even though the company lowered its earnings-per-share (EPS) outlook for the full year and the current quarter. The company, however, reiterated its outlook for organic revenue growth of 5% to 7%.

Philip Morris Earnings Beat Keeps Growth Story IntactThe headline numbers were solid. Revenue of $11.19 billion beat analysts’ expectations for $10.61 billion and was higher than the $10.14 billion in Q2 2025. Adjusted EPS of $2.20 was also above the estimate of $2.04 and above the $1.91 adjusted EPS from the prior year quarter.

A closer look at the EPS guidance may explain why investors are looking past the report. Philip Morris guided to adjusted EPS between $8.26 and $8.41 per share. That’s down 10 cents from both ends on its prior guidance of $8.26 to $8.51. However, even at the low end, it marks a 7.5% year-over-year (YOY) increase.

That's stronger growth than some models have factored in, suggesting the stock is undervalued. On the other hand, PM is up 20% year-to-date, and skeptics may believe that much of that future earnings growth is priced in.

Smoke-Free Products Keep Doing the Heavy LiftingThe quarter's real story is how much of that growth is coming from products that didn't exist in Philip Morris's portfolio a decade ago. International smoke-free net revenue grew 13.7% organically in the first half, with gross profit up 16.9% and gross margin expanding 190 basis points to 70%.

That's significantly more profitable than its legacy cigarette business, even though combustibles are hardly fading. International combustible gross profit still grew 6.1% organically in H1, with pricing power alone contributing 9.2% growth in the category.

IQOS remains the anchor of that smoke-free push, now sold in 80 markets, with the heated tobacco unit adjusted in-market sales growth of 11.3% in H1, excluding Japan and Poland, two markets facing temporary headwinds. Management pointed to a Kantar BrandZ ranking as one of 2026's most valuable global brands as evidence the platform still has room to run. Meanwhile, VEEV, the company's e-vapor brand, posted 72% shipment growth and became the top closed-pod brand in Europe with a 21.3% share, overtaking both of its nearest competitors during the past year.

ZYN, the nicotine pouch brand at the center of Philip Morris's U.S. growth story, shipped 2.9 billion pouches in Q2, up 25% sequentially from Q1, with a U.S. retail value share of 57.1%. The company is leaning further into that momentum, launching a ZYN Ultra range and new flagship dry flavors in June, with additional nicotine-strength variants due in Q3, backed by a new "When it clicks" ad campaign. ZYN also holds the first and only Modified Risk Tobacco Product authorization in its category, covering 20 SKUs, which the company is using as a differentiator against competitors.

Pricing Power Adds to the Growth StoryOf the 9.8% net revenue growth in the first half of 2026, pricing across both combustibles and smoke-free products contributed 5.9 percentage points. A favorable mix shift toward smoke-free products added another two points internationally.

That means roughly 80% of organic revenue growth is coming from the company charging more and selling a richer mix of products, not simply moving more volume. Total shipment volume was essentially flat in the half at 389.4 billion units, though it returned to positive growth in Q2, up 2.5% year-over-year, with SFP shipments climbing 7.5% in the quarter.

Overall MarketRank™82nd Percentile

Analyst RatingModerate Buy

Upside/Downside3.1% Upside

Short Interest LevelHealthy

Dividend StrengthStrong

News Sentiment0.91 Insider TradingN/A

Proj. Earnings Growth10.04%

See Full Analysis

This is an important distinction for anyone modeling out the next few years. Pricing power historically compounds more reliably than volume growth for tobacco and nicotine companies, since regulatory and health pressures tend to cap unit growth over the long run. Philip Morris's own guidance for 2026 reflects revenue and EPS that model above the flat-to-low-single-digit volume trends the industry has seen for years.

Management also reiterated its targeting a sixth consecutive year of currency-neutral volume growth, a streak that would have seemed unlikely for a cigarette company a decade ago.

On the U.S. side specifically, sequential improvement was notable, with net revenues climbing 38% from Q1 to Q2 and adjusted gross profit up 46% over the same period, even as the company continues to invest heavily in ZYN's portfolio expansion. Management framed this as an early step in what it called a "substantial U.S. smoke-free opportunity," suggesting more investment — and potentially more short-term margin pressure — is still to come as new product variants roll out through Q3.

Investors should also note management's continued commitment to shareholder returns even amid this reinvestment phase. The company projected roughly $13.5 billion in operating cash flow for the year, underscoring that the company’s growth investments aren't coming at the expense of the balance sheet.

Is Philip Morris Stock Ready to Break Out After Earnings?Investors may feel like it’s Groundhog Day as PM stock is at a level that has provided resistance over the last two years. This pattern of retracing a path back to a level of resistance is usually a bullish sign, but it requires patience, which PM shareholders have had to have.

Nevertheless, the stock looks ready to break out, and at least one analyst agrees. BTIG Research initiated coverage of Philip Morris on July 21, setting a price target of $216. That’s well above the consensus price target of $197.

Investors in Philip Morris also get to enjoy the company’s dividend, which has a yield of 3.03% as of July 21 and has increased its payout for 17 consecutive years. This was the fourth consecutive quarter at the prior payout rate, so it’s likely that there will be an increase in the next quarter or two.

Should You Invest $1,000 in Philip Morris International Right Now?Before you consider Philip Morris International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Philip Morris International wasn't on the list.

While Philip Morris International currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN) between August 1, 2025 and May 15, 2026, inclusive. Should You Join The Regeneron Class Action Lawsuit : Do you, or did you, own shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)?

The PHLX Semiconductor Sector index has jumped by an impressive 68% this year despite the recent sell-off in this sector. These impressive gains have been fueled by the terrific demand for chips, which play a critical role in powering artificial intelligence (AI) infrastructure.

However, shares of Taiwan Semiconductor Manufacturing (TSM -0.50%) have underperformed the semiconductor sector in 2026, gaining just 33% as of this writing. This is even though TSMC is one of the most important companies in the AI infrastructure ecosystem. Its latest results provide further indication that it is winning big from the massive spending on AI data centers.

More importantly, TSMC is well-positioned to continue benefiting from the AI infrastructure boom. Let's look at the reasons why it seems like a bad idea to overlook this solid semiconductor stock.

Image source: TSMC.

TSMC's growth rate is picking up thanks to AI infrastructure spending TSMC released its second-quarter 2026 earnings report on July 16. The company's revenue increased 34% year over year to $40.2 billion, while earnings per share jumped by an even more impressive 77% from the year-ago period to $4.31. The numbers exceeded analysts' expectations, and its guidance was the icing on the cake.

Today's Change

(

-0.50

%) $

-2.09

Current Price

$

419.12

TSMC anticipates Q3 revenue of $45.2 billion, which points to a 37% jump from the year-ago period. Even better, the company sees its operating margin increase to 57% in the current quarter, up from 50.6% in the year-ago quarter. This points toward another major jump in TSMC's bottom line. Wall Street anticipates a 54% year-over-year increase in TSMC's earnings in the current quarter. However, the company's guidance suggests it could do better than that, primarily due to a significant increase in its margins.

Also, TSMC has increased its full-year guidance. It now expects 2026 revenue to increase by more than 40%, up from the earlier estimate of 30%-plus growth. TSMC attributes the stronger guidance to the growing demand for AI chips. Management noted on the latest earnings call that AI is driving "the need for more and more computation," with applications such as agentic AI driving a resurgence in central processing units (CPUs).

Looking ahead, AI infrastructure spending could jump from an estimated $1 trillion in 2027 to $3-$4 trillion in 2030, according to industry bellwether Nvidia. This indicates that TSMC's incredible growth will continue in the long run, given that it is the go-to manufacturer for chips for the leading AI chip designers, including Nvidia, AMD, Qualcomm, Broadcom, and others.

Not surprisingly, there has been a significant uptick in TSMC's earnings forecast following its quarterly report.

The stock can go on a terrific bull run TSMC stock may have underperformed the broader market this year, but don't be surprised if it steps on the gas. We have already seen that the company is growing at an impressive pace, and it can sustain its momentum over the long run due to the secular growth of the AI infrastructure space.

What's more, investors can buy TSMC at 25 times forward earnings right now, which is in line with the Nasdaq-100 index's forward earnings multiple. If TSMC's earnings per share indeed reach $28.03 in 2028 and it trades at 25 times earnings at that time, its stock price could jump to $700. That's a potential gain of 67% in less than three years, which is why investors should consider buying this AI stock before it regains its mojo.

Harsh Chauhan has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices, Broadcom, Nvidia, Qualcomm, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.

Thermo Fisher Scientific (TMO - Free Report) came out with quarterly earnings of $6.03 per share, beating the Zacks Consensus Estimate of $5.71 per share. This compares to earnings of $5.36 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +5.60%. A quarter ago, it was expected that this maker of scientific instrument and laboratory supplies would post earnings of $5.2 per share when it actually produced earnings of $5.44, delivering a surprise of +4.62%.

Over the last four quarters, the company has surpassed consensus EPS estimates four times.

Thermo Fisher, which belongs to the Zacks Medical - Instruments industry, posted revenues of $11.99 billion for the quarter ended June 2026, surpassing the Zacks Consensus Estimate by 2.67%. This compares to year-ago revenues of $10.86 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Thermo Fisher shares have lost about 9.1% since the beginning of the year versus the S&P 500's gain of 9.6%.

What's Next for Thermo Fisher?While Thermo Fisher has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Thermo Fisher was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $6.36 on $11.95 billion in revenues for the coming quarter and $24.84 on $47.73 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - Instruments is currently in the bottom 35% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

DarioHealth Corp. (DRIO - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.

This company is expected to post quarterly loss of $0.74 per share in its upcoming report, which represents a year-over-year change of +69.2%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

DarioHealth Corp.'s revenues are expected to be $6.19 million, up 15.3% from the year-ago quarter.

The $25K Day Trading Barrier is Gone

The long-standing Pattern Day Trader (PDT) rule that required many traders to maintain a $25,000 account balance is no longer standing in the way.

That means more traders can actively pursue short-term opportunities without the barrier that kept so many on the sidelines.

Now it's all about having the right strategy.

Dynamite Day Trading Signals helps you hit the ground running with up 2 options trade alerts per week, built to capture fast-moving opportunities.  

👉 Sign up now to receive the next trade

Texas Instruments Inc (NASDAQ:TXN) reported upbeat second-quarter results after the market close on Wednesday.

Texas Instruments reported second-quarter revenue of $5.46 billion, beating analyst estimates of $5.25 billion. The semiconductor company posted second-quarter earnings of $2.14 per share, beating analyst estimates of $1.92 per share, according to Benzinga Pro.

"Our cash flow from operations of $8.7 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production," said Haviv Ilan, chairman, president and CEO of Texas Instruments.

Texas Instruments expects third-quarter revenue to be in the range of $5.65 billion to $6.15 billion versus estimates of $5.61 billion. The company anticipates third-quarter earnings of $2.23 to $2.57 per share versus estimates of $2.15 per share.

Texas Instruments shares fell 5.2% to $278.99 in pre-market trading.

These analysts made changes to their price targets on Texas Instruments following earnings announcement.

Keybanc analyst John Vinh maintained the stock with an Overweight rating and raised the price target from $390 to $400. Evercore ISI Group analyst Mark Lipacis maintained the stock with an Outperform rating and raised the price target from $316 to $330. Considering buying TXN stock? Here’s what analysts think:

Photo via Shutterstock

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.

OMAHA, Neb.--(BUSINESS WIRE)--Union Pacific Corporation (NYSE: UNP) today reported second quarter 2026 net income of $2.0 billion, up 6%, and diluted EPS of $3.36, up 7%, compared to reported second quarter 2025 net income of $1.9 billion and diluted EPS of $3.15. Adjusted second quarter 2026 net income* of $2.0 billion increased 12%, and adjusted diluted EPS* of $3.41 increased 13%, compared to adjusted second quarter 2025 net income* of $1.8 billion and adjusted diluted EPS* of $3.03. "Strong.

Union Pacific reported higher profit and revenue in the second quarter, boosted in part by volume growth.

RTX Corp (RTX) released its 8-K filing on July 23, 2026, showcasing robust growth in its second-quarter earnings. The aerospace and defense manufacturer, formed

In this article

RTX

SPX

DJIA

Coming into Thursday trading, RTX stock was up 6% year to date, but down 4% since fighting started in Iran. (Luke Sharrett/Getty Images)

Amid war and rising oil prices, RTX delivered the kind of quarters investors craved: A beat-and-raise. That’s providing some relief, but the company’s customers still need more jet engines.

Morgan Stanley stock has wavered recently, evem as the Wall Street company published strong financial results. MS was trading at $218, a few points below its all-time high of $232. This consolidation may lead to a strong rebound after a major Goldman Sachs prediction.

Morgan Stanley is benefiting from major trends in the US this year. Mega IPOs are rising, and analysts expect that merger and acquisition (M&A) deals will accelerate in the near term. 

Morgan Stanley was one of the banks that made a windfall from the recent SpaceX IPO. It is estimated that the company made over $100 million in the process.

The bank will likely benefit from more IPOs, including companies like Anthropic and OpenAI. 

Most notably, Goldman Sachs analysts predict that the merger and acquisition boom has more room to run. Announced M&A deals have jumped by 32% this year to $1.2 trillion. The number of announced deals has soared by 12% in then same period. 

In a report, the bank said that this trend will continue, helped by a steady economic growth, healthy CEO confidence, and a favorable regulatory backdrop. The bank added that: 

“Likely M&A targets should benefit from the ongoing surge in M&A activity, which does not appear to be fully priced in their valuations.”

If this is correct, then Morgan Stanley will be one of the top beneficiaries. Dealogic data estimates that it is the third in the M&A industry this year after Goldman and JPMorgan. It has been involved in deals worth over $831 billion. 

The company also ranks third in the equity capital markets (ECM) bookrunning with its deal value rising to $51 billion. It has also become a major player in debt raising industry.

These numbers are confirmed by its recent financial results, which showed that its net revenue jumped by 27% YoY to $21.3 billion. It was a $1 billion increase from the previous quarter. 

Institutional securities revenue rose by 44% to $11 billion, while its wealth and investment management rose by 14% and 6%, respectively. These ones rose to $8.8 billion and $1.6 billion. Notably, the provision for credit losses dropped to just $98 million during the quarter. Ted Pick, the CEO said:

“Differentiated content from our Research teams continues to drive high levels of client engagement. Wealth Management added a record $148 billion in net new assets, with total client assets across Wealth and Investment Management reaching the $10 trillion milestone.”

MS stock chart | Source: TradingView

Technically, however, the MS stock price will need to overcome the double-top pattern at $230, and whose neckline is at $230. Also, the stock needs to overcome the mean reversion risk. Mean reversion is a situation where an asset normally moves to its historical averages. In this case, the stock is much higher than the 200-day moving average of $184. 

Therefore, there is a risk that it will pull back in the near term because of its weak technicals. On the other hand, a move above the key resistance level of $230 will point to more gains, potentially to the key resistance at $250.

ServiceNow (NOW) raised its full-year subscription revenue forecast after another strong quarter, as rapid adoption of its AI products helped the software compa

ServiceNow Inc (NYSE:NOW, XETRA:4S0) forecast third-quarter results above Wall Street expectations and posted second-quarter earnings that beat analyst estimates.

The company reported second-quarter subscription revenue of $3.88 billion, up 24.5% from a year earlier, while total revenue reached $3.99 billion, ahead of analyst estimates of $3.92 billion.

Adjusted earnings per share came in at $0.90, topping estimates of $0.86.

Current remaining performance obligations (cRPO), a closely watched bookings metric, rose 21% year-over-year to $13.20 billion, above estimates of roughly $13.03 billion.

For the third quarter, ServiceNow guided subscription revenue of $3.975 billion to $3.98 billion and cRPO growth of 19.5% year-over-year, ahead of analyst estimates of 18% to 19% growth.

The company raised its full-year subscription revenue guidance to a range of $15.76 billion to $15.78 billion, representing growth of 22.5% year-over-year. It maintained its outlook for subscription gross margin of 81%, operating margin of 31.5% and free cash flow margin of 35%.

ServiceNow said its artificial intelligence business surpassed $1 billion in annual contract value during the quarter, as the company continues to expand its AI product offerings.

The company also reported 658 customers with more than $5 million in annual contract value, up 23% from a year earlier, and 123 transactions exceeding $1 million in annual contract value, up about 40%.

Adjusted operating margin was 29.5%, above estimates of 26.5% and flat year-over-year. Free cash flow totaled $634 million, a 16% margin, below estimates of $679 million.

Shares fluctuated around the flatline on Thursday, adding a modest 0.5% to its opening levels.

Lockheed Martin's stock jumps as a ramp up in missile production helped lead to an earnings beat and raise.

COLUMBUS, Ind.--(BUSINESS WIRE)--Cummins Inc. (NYSE: CMI) today announced updates to its Model Year 2027 North American on-highway product launch plans following its review of the U.S. Environmental Protection Agency's recently proposed changes to upcoming emissions regulations. Based on the proposed rule, Cummins intends to use the implementation flexibilities outlined by EPA to support a measured transition to its new HELM™ engine platforms. The approach is designed to maintain regulatory com.

Coinbase's rising take rate reflects new derivatives and prediction-market revenue, while record loan balances and tokenization deployments point to growing institutional platform adoption. AI adoption is raising engineering output while sharply reducing AI costs, supporting a leaner expense base and $500M of cost savings. A CLARITY Act passage before Congress's August recess could reduce regulatory uncertainty and accelerate institutional crypto activity on Coinbase's platform.

Posted by Defense World Staff on Jul 23rd, 2026

Baader Bank Aktiengesellschaft decreased its stake in shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) by 76.2% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,250 shares of the network technology company’s stock after selling 7,206 shares during the quarter. Baader Bank Aktiengesellschaft’s holdings in Palo Alto Networks were worth $361,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in PANW. Norges Bank acquired a new position in Palo Alto Networks during the fourth quarter worth $1,415,364,000. Vanguard Group Inc. lifted its stake in Palo Alto Networks by 4.1% in the fourth quarter. Vanguard Group Inc. now owns 67,929,063 shares of the network technology company’s stock valued at $12,512,533,000 after acquiring an additional 2,659,100 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its stake in Palo Alto Networks by 1,665.1% in the first quarter. Harel Insurance Investments & Financial Services Ltd. now owns 2,761,909 shares of the network technology company’s stock valued at $442,788,000 after acquiring an additional 2,605,433 shares during the last quarter. Bank of America Corp DE grew its position in shares of Palo Alto Networks by 11.9% in the 4th quarter. Bank of America Corp DE now owns 19,375,486 shares of the network technology company’s stock valued at $3,568,964,000 after acquiring an additional 2,065,776 shares during the period. Finally, Employees Provident Fund Board bought a new position in shares of Palo Alto Networks in the 4th quarter valued at about $281,542,000. Institutional investors own 79.82% of the company’s stock.

Trending Headlines about Palo Alto Networks Here are the key news stories impacting Palo Alto Networks this week:

Positive Sentiment: Analysts and commentators continue to highlight Palo Alto Networks as a key beneficiary of rising AI-driven cybersecurity spending, with Morgan Stanley saying sentiment on software stocks may be too negative and Barron’s arguing PANW could be a major winner in the new AI era. Article: Morgan Stanley Analysts Say Sentiment Has Gotten ‘Too Negative’ on Software Stocks. These Are Their Picks Positive Sentiment: Market watchers are also pointing to broader enterprise demand for cybersecurity as AI agents proliferate, which could support future security product spending and reinforce PANW’s growth narrative. Article: Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending Positive Sentiment: Palo Alto Networks announced it will acquire Embrace to extend its observability platform with Real User Monitoring and Synthetics, a move aimed at improving digital experience monitoring and AI-driven operations. Investors may see this as an expansion into a higher-value adjacent market. Article: Palo Alto Networks to Extend Leading Observability Platform with Innovative Digital Experience Monitoring Neutral Sentiment: Another brief note flagged PANW as a cybersecurity stock to follow, but did not add any new catalyst beyond the broader sector interest. Article: Cybersecurity Stocks To Follow Now – July 20th Negative Sentiment: Despite the upbeat long-term themes, one article noted PANW had slipped intraday, suggesting some investors are still taking profits or reacting to overall software sector weakness. Article: Palo Alto slips 3%: Why this analyst still sees it as a top cyber pick Palo Alto Networks Price Performance Palo Alto Networks stock opened at $335.28 on Thursday. The firm has a market cap of $273.25 billion, a PE ratio of 274.82, a price-to-earnings-growth ratio of 12.70 and a beta of 0.91. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.86 and a quick ratio of 0.86. The stock’s fifty day moving average price is $297.43 and its two-hundred day moving average price is $215.80. Palo Alto Networks, Inc. has a one year low of $139.57 and a one year high of $368.80.

Palo Alto Networks (NASDAQ:PANW – Get Free Report) last released its earnings results on Tuesday, June 2nd. The network technology company reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.79 by $0.06. The firm had revenue of $3 billion during the quarter, compared to the consensus estimate of $2.94 billion. Palo Alto Networks had a return on equity of 10.53% and a net margin of 7.95%.The company’s revenue was up 31.1% compared to the same quarter last year. During the same period in the prior year, the company posted $0.37 EPS. Palo Alto Networks has set its FY 2026 guidance at 3.770-3.790 EPS and its Q4 2026 guidance at 0.960-0.980 EPS. As a group, research analysts expect that Palo Alto Networks, Inc. will post 2.03 EPS for the current fiscal year.

Insider Buying and Selling at Palo Alto Networks In other Palo Alto Networks news, Director Helle Thorning-Schmidt sold 700 shares of the stock in a transaction dated Tuesday, July 7th. The shares were sold at an average price of $346.85, for a total transaction of $242,795.00. Following the sale, the director directly owned 5,898 shares in the company, valued at $2,045,721.30. This represents a 10.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Josh D. Paul sold 900 shares of the firm’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $345.00, for a total transaction of $310,500.00. Following the completion of the transaction, the chief accounting officer directly owned 79,644 shares in the company, valued at approximately $27,477,180. This represents a 1.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 101,239 shares of company stock valued at $27,174,360 over the last three months. 1.40% of the stock is owned by insiders.

Wall Street Analyst Weigh In A number of brokerages have recently issued reports on PANW. Robert W. Baird set a $320.00 target price on shares of Palo Alto Networks in a report on Wednesday, June 3rd. Evercore reiterated an “outperform” rating and set a $415.00 price target on shares of Palo Alto Networks in a report on Wednesday, July 8th. DA Davidson boosted their price target on Palo Alto Networks from $190.00 to $345.00 and gave the stock a “buy” rating in a research report on Wednesday, June 3rd. Weiss Ratings lowered Palo Alto Networks from a “hold (c)” rating to a “hold (c-)” rating in a research note on Thursday, June 4th. Finally, Wells Fargo & Company raised their price objective on Palo Alto Networks from $325.00 to $420.00 and gave the company an “overweight” rating in a research report on Wednesday, July 1st. One research analyst has rated the stock with a Strong Buy rating, forty have assigned a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $331.48.

Check Out Our Latest Stock Analysis on Palo Alto Networks

Palo Alto Networks Profile (Free Report)

Palo Alto Networks (NASDAQ: PANW) is a cybersecurity company founded in 2005 and headquartered in Santa Clara, California. The firm develops a broad suite of security products and services designed to prevent successful cyberattacks and protect enterprise networks, clouds, and endpoints. Built around a platform strategy, its offerings target threat prevention, detection, response and governance across hybrid and multi-cloud environments.

The company’s product portfolio includes next‑generation firewalls as a core on‑premises capability, alongside cloud‑delivered security services and software for securing public and private clouds.

See Also Five stocks we like better than Palo Alto Networks Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play

Receive News & Ratings for Palo Alto Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palo Alto Networks and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAR Asset Management Inc. Purchases New Position in Ares Management Corporation $ARES

NEXT HEADLINE »Aureus Asset Management LLC Raises Stock Position in Palo Alto Networks, Inc. $PANW

Posted by Defense World Staff on Jul 23rd, 2026

B&D White Capital Company LLC bought a new stake in shares of Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,200 shares of the network technology company’s stock, valued at approximately $353,000.

A number of other hedge funds and other institutional investors have also modified their holdings of PANW. Darwin Wealth Management LLC acquired a new position in shares of Palo Alto Networks in the 2nd quarter valued at approximately $25,000. Steph & Co. increased its stake in shares of Palo Alto Networks by 88.2% in the fourth quarter. Steph & Co. now owns 143 shares of the network technology company’s stock worth $26,000 after buying an additional 67 shares during the last quarter. Knuff & Co LLC bought a new stake in shares of Palo Alto Networks in the fourth quarter worth $26,000. Sittner & Nelson LLC raised its holdings in Palo Alto Networks by 73.8% in the fourth quarter. Sittner & Nelson LLC now owns 146 shares of the network technology company’s stock valued at $27,000 after acquiring an additional 62 shares in the last quarter. Finally, Luken Investment Analytics LLC raised its holdings in Palo Alto Networks by 196.2% in the fourth quarter. Luken Investment Analytics LLC now owns 154 shares of the network technology company’s stock valued at $28,000 after acquiring an additional 102 shares in the last quarter. 79.82% of the stock is owned by hedge funds and other institutional investors.

Key Stories Impacting Palo Alto Networks Here are the key news stories impacting Palo Alto Networks this week:

Positive Sentiment: Analysts and commentators continue to highlight Palo Alto Networks as a key beneficiary of rising AI-driven cybersecurity spending, with Morgan Stanley saying sentiment on software stocks may be too negative and Barron’s arguing PANW could be a major winner in the new AI era. Article: Morgan Stanley Analysts Say Sentiment Has Gotten ‘Too Negative’ on Software Stocks. These Are Their Picks Positive Sentiment: Market watchers are also pointing to broader enterprise demand for cybersecurity as AI agents proliferate, which could support future security product spending and reinforce PANW’s growth narrative. Article: Citi Wealth CIO Warns “Infinite AI Agents” Will Accelerate Cybersecurity’s Share of Enterprise Spending Positive Sentiment: Palo Alto Networks announced it will acquire Embrace to extend its observability platform with Real User Monitoring and Synthetics, a move aimed at improving digital experience monitoring and AI-driven operations. Investors may see this as an expansion into a higher-value adjacent market. Article: Palo Alto Networks to Extend Leading Observability Platform with Innovative Digital Experience Monitoring Neutral Sentiment: Another brief note flagged PANW as a cybersecurity stock to follow, but did not add any new catalyst beyond the broader sector interest. Article: Cybersecurity Stocks To Follow Now – July 20th Negative Sentiment: Despite the upbeat long-term themes, one article noted PANW had slipped intraday, suggesting some investors are still taking profits or reacting to overall software sector weakness. Article: Palo Alto slips 3%: Why this analyst still sees it as a top cyber pick Wall Street Analyst Weigh In Several research analysts have weighed in on PANW shares. Stephens raised their price objective on shares of Palo Alto Networks from $180.00 to $300.00 and gave the stock an “equal weight” rating in a report on Wednesday, June 3rd. BTIG Research increased their price target on shares of Palo Alto Networks from $333.00 to $380.00 and gave the stock a “buy” rating in a research report on Tuesday, June 30th. BNP Paribas Exane lifted their price target on Palo Alto Networks from $330.00 to $380.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 1st. Jefferies Financial Group set a $335.00 price objective on Palo Alto Networks and gave the company a “buy” rating in a report on Wednesday, June 3rd. Finally, Oppenheimer upped their price objective on Palo Alto Networks from $275.00 to $350.00 and gave the company an “outperform” rating in a research note on Wednesday, June 3rd. One equities research analyst has rated the stock with a Strong Buy rating, forty have issued a Buy rating, seven have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Palo Alto Networks currently has an average rating of “Moderate Buy” and a consensus price target of $331.48.

Get Our Latest Research Report on PANW

Palo Alto Networks Trading Down 2.0% NASDAQ PANW opened at $335.28 on Thursday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 0.86 and a current ratio of 0.86. Palo Alto Networks, Inc. has a one year low of $139.57 and a one year high of $368.80. The company has a 50-day simple moving average of $297.43 and a 200-day simple moving average of $215.80. The firm has a market capitalization of $273.25 billion, a PE ratio of 274.82, a price-to-earnings-growth ratio of 12.70 and a beta of 0.91.

Palo Alto Networks (NASDAQ:PANW – Get Free Report) last released its quarterly earnings data on Tuesday, June 2nd. The network technology company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.79 by $0.06. Palo Alto Networks had a net margin of 7.95% and a return on equity of 10.53%. The firm had revenue of $3 billion for the quarter, compared to analyst estimates of $2.94 billion. During the same quarter in the prior year, the business earned $0.37 earnings per share. Palo Alto Networks’s quarterly revenue was up 31.1% on a year-over-year basis. Palo Alto Networks has set its FY 2026 guidance at 3.770-3.790 EPS and its Q4 2026 guidance at 0.960-0.980 EPS. On average, equities analysts forecast that Palo Alto Networks, Inc. will post 2.03 earnings per share for the current year.

Insider Activity In other Palo Alto Networks news, Director John P. Key sold 7,500 shares of the firm’s stock in a transaction on Friday, June 12th. The stock was sold at an average price of $279.24, for a total value of $2,094,300.00. Following the sale, the director directly owned 12,500 shares in the company, valued at approximately $3,490,500. This trade represents a 37.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Josh D. Paul sold 1,100 shares of the business’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $285.08, for a total transaction of $313,588.00. Following the transaction, the chief accounting officer directly owned 81,636 shares of the company’s stock, valued at approximately $23,272,790.88. This trade represents a 1.33% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 101,239 shares of company stock worth $27,174,360 over the last 90 days. Insiders own 1.40% of the company’s stock.

Palo Alto Networks Company Profile (Free Report)

Palo Alto Networks (NASDAQ: PANW) is a cybersecurity company founded in 2005 and headquartered in Santa Clara, California. The firm develops a broad suite of security products and services designed to prevent successful cyberattacks and protect enterprise networks, clouds, and endpoints. Built around a platform strategy, its offerings target threat prevention, detection, response and governance across hybrid and multi-cloud environments.

The company’s product portfolio includes next‑generation firewalls as a core on‑premises capability, alongside cloud‑delivered security services and software for securing public and private clouds.

Read More Five stocks we like better than Palo Alto Networks Could Truth API Become Trump Media’s First Meaningful Revenue Driver? Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying Moog Is More Than a Missile Maker, and Wall Street Is Noticing A Boring Dividend Growth Strategy Becomes a Solid Defensive Play Want to see what other hedge funds are holding PANW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Palo Alto Networks, Inc. (NASDAQ:PANW – Free Report).

Receive News & Ratings for Palo Alto Networks Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palo Alto Networks and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEBessemer Group Inc. Has $2.29 Million Position in CenterPoint Energy, Inc. $CNP

NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of Roblox Corporation (“Roblox” or the “Company”) (NYSE: RBLX) between October 31, 2024 and April 30, 2026, inclusive.

Should You Join The Roblox Corporation Class Action Lawsuit:

Do you, or did you, own shares of Roblox Corporation (NYSE: RBLX)?Did you purchase your shares between October 31, 2024 and April 30, 2026, inclusive?Did you lose money in your investment in Roblox Corporation?
What To Do Next:

Investors are encouraged to act promptly and submit a form at Roblox Corporation Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected].

If you wish to serve as lead plaintiff for the Class, you must file papers by August 7, 2026. A lead plaintiff is a representative party acting on other class members’ behalf in directing the litigation. Your ability to share in any recovery doesn’t require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About The Lawsuit:

The lawsuit alleges that defendants made materially false and misleading statements and omissions regarding the Company’s business operations, growth prospects, and financial stability. As a result of these alleged misrepresentations, Roblox common stock traded at artificially inflated prices during the Class Period. When the truth was disclosed, investors allegedly suffered significant losses.

About Bernstein Liebhard:

Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal’s “Plaintiffs’ Hot List” thirteen times and listed in The Legal 500 for sixteen consecutive years.

ATTORNEY ADVERTISING. © 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:

Peter Allocco
Investor Relations Manager
Bernstein Liebhard LLP
https://www.bernlieb.com
(212) 951-2030
[email protected]

Annaly Capital Management is rated a Strong Buy for its 13.38% dividend yield and significant capital appreciation potential by 2030. NLY's diversified REIT model, resilient through multiple economic cycles, benefits from agency MBS, MSR, and residential credit strategies with yields up to 16%. I expect falling interest rates to expand NLY's net interest margin, driving both dividend growth and share price appreciation toward a $40 target by 2030.

23.7.2026 15:52, BAACSG

Společnost CSG oznámila, že v souvislosti se vstupem na burzu (IPO) a zvýšením svého úvěrového ratingu zajistila refinancování části seniorních úvěrů formou nového syndikovaného úvěru v objemu až 3,062 mld. EUR.

Nová dluhová struktura podle společnosti omezuje riziko koncentrace refinancování v roce 2029 a prodlužuje splatnost seniorního dluhu až na šest let. Díky novému a navýšenému revolvingovému úvěrovému rámci společnost zároveň získává výrazně vyšší flexibilitu při financování provozního kapitálu.

Transakce zaznamenala na trhu silnou poptávku a společnosti přináší snížení úrokových nákladů o 125 až 150 bazických bodů oproti předchozím syndikovaným úvěrům.

Objem čerpaných prostředků z nové úvěrové struktury zůstane při dokončení transakce na stejné úrovni jako u původní struktury, tedy na hodnotě přibližně 1,7 mld. EUR. Společnost zároveň potvrdila svůj výhled zadlužení pro fiskální rok 2026, ve kterém počítá s poměrem čistého dluhu k zisku EBITDA pod úrovní 1,3×.

Nová dluhová struktura Plně komitovaný syndikovaný úvěr v celkové výši až 3,062 mld. EUR (2,867 mld. EUR a 225 mil. USD), který zahrnuje:

TLB ve výši 717 mil. EUR, se splatností 22. listopadu 2029, jednorázově splatný při konečné splatnosti (bullet). TLC ve výši 850 mil. EUR, se splatností 6 let od data uzavření transakce, jednorázově splatný při konečné splatnosti (bullet). Revolvingovou úvěrovou linku (Revolving Credit Facility) se dvěma tranšemi (až 1,3 mld. EUR a až 225 mil. USD) se splatností 3 roky od data uzavření transakce s možností prodloužení. Předchozí dluhová struktura Dva syndikované seniorní úvěry (až 1,545 mld. EUR a až 600 mil. EUR), oba se splatností 22. listopadu 2029, s celkovým čerpáním přibližně 1,7 mld. EUR. Akcie CSG Akcie CSG (BAACSG) dnes na pražské burze klesají o 0,05 % na 392,8 Kč, na RM-SYSTÉMu pak posilují o 1 % na 393 Kč.

Zdroj: CSG

Michal Šnobl
Fio banka, a.s.
Prohlášení

Freeport-McMoRan Inc (FCX) released its 8-K filing on July 23, 2026, detailing its financial performance for the second quarter of 2026. The company, a powerhou

Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)

USA News Group News Commentary

, /PRNewswire/ -- For years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk about accelerating the search for new medicines; far fewer can point to real revenue, real clients, and a business model that compounds. One small-cap AI biotech just put a set of numbers behind its version of that story, and they show a company whose pivot is starting to appear in its financials rather than only in its slide decks.

The company reported full-year results that pair a sharp revenue increase with a dramatically narrower loss, and, for the first time, contracted recurring platform revenue. Taken together, the report is the clearest evidence yet of the shift it has been promising: from one-off project work toward a durable, recurring software business.

Key Takeaways

MindWalk Holdings Corp. (NASDAQ: HYFT) reported fiscal 2026 revenue up 46% to C$15.6 million, with gross margin expanding to roughly 59% and the net loss for the year narrowing by more than half.

The company signed its first two contracted, recurring enterprise LensAI™ agreements during the year, the first recurring platform revenue in its history, and regained Nasdaq listing compliance without a reverse split or dilutive financing.

The broader AI-platform and computational-biology field includes Schrödinger (NASDAQ: SDGR), AbCellera Biologics (NASDAQ: ABCL), Relay Therapeutics (NASDAQ: RLAY), and Certara (NASDAQ: CERT), each pursuing its own model for turning software and data into durable revenue.

The Numbers Behind the Pivot 

MindWalk Holdings Corp. (Nasdaq: HYFT), a Bio-Native AI company focused on drug discovery, reported financial results for the fiscal year ended April 30, 2026. Revenue rose 46% year over year to C$15.6 million, up from C$10.6 million a year earlier, while gross profit grew about 60% to C$9.1 million and gross margin expanded to 58.8% from 53.9%. The company reported these as preliminary results ahead of the filing of its Annual Report on Form 20-F, and all figures are in Canadian dollars.

Just as striking as the top line was the bottom line. Total operating expenses fell about 44% to C$24.1 million from C$42.6 million, a decline the company attributed primarily to the non-recurrence of roughly C$22.7 million of prior-year non-cash amortization and impairment of intangible assets and goodwill. Net loss from continuing operations narrowed to C$15.1 million from C$33.1 million, and net loss for the year narrowed to C$13.9 million from C$30.2 million, an improvement of more than half. Loss per share from continuing operations improved to C$0.33 from C$0.99. The company ended the year with C$11.5 million in cash and restricted cash.

In the fourth quarter, revenue rose 50% to C$4.1 million from C$2.7 million a year earlier, with gross margin of roughly 60.6%, capping four consecutive quarters of year-over-year revenue growth. The pattern is the story the company wants investors to see: growth that is not only accelerating but improving in quality as higher-margin platform work enters the mix.

From Project Work to Recurring Revenue

The single most important disclosure for the investment thesis was not a headline financial figure but a structural one. During the fiscal year, MindWalk signed its first two contracted, recurring enterprise LensAI agreements, one in the second half and one in the fourth quarter, which it described as the first recurring platform revenue in the company's history. That is the shift the company has been arguing it could make: away from one-time, fee-for-service engagements and toward the kind of durable, contracted revenue the market tends to value more highly.

"We are not an AI company that discovered biology. We are a biology company that built AI on top of more than 40 years of biology heritage, and fiscal 2026 is the year the market began to see it in our results," said Dr. Jennifer Bath, President and Chief Executive Officer of MindWalk. "Revenue grew 46%, margins expanded, and we simplified the business around the layer where enterprise AI value accrues. HYFT Technology powers ReefIQ, the biological context layer for life sciences, and LensAI is in contracted, recurring arrangements with life sciences customers today. Value compounds in that layer, not in any individual model that runs on top of it."

The company also cleaned up its structure during the year. It completed its transformation into MindWalk Holdings Corp. from ImmunoPrecise Antibodies Ltd. in September 2025, and divested its Netherlands subsidiary, ImmunoPrecise Antibodies (Europe) B.V., to AVS Bio, a portfolio company of Arlington Capital Partners, in a transaction that generated proceeds on disposal of approximately C$14.3 million and was supported by a 12-month transition services agreement. Management framed the divestiture as sharpening focus on the core business and strengthening the balance sheet, and separately noted it had regained Nasdaq listing compliance organically, without a reverse split or dilutive financing.

The Platform Underneath the Story

MindWalk positions itself as a Bio-Native AI company, meaning it aims to reason over biology itself rather than over language the way general-purpose AI models do. Its technology is built in layers. HYFT® Technology provides a representation foundation, a function-aware map of biology built over 20 years of curation and spanning 660 million biological patterns connected by 25 billion relationships. ReefIQ™, launched commercially in June 2026 and built on that foundation, is the biological context layer that organizes and governs a client's data. LensAI is the reasoning layer that applies analytical workflows on top. In the company's framing, the durable, compounding asset is the context layer rather than any individual model that runs on it, because every program a customer runs enriches the layer for the next one.

The company pointed to several recent milestones beyond the financials: the June 2026 commercial launch of ReefIQ, the filing of a European patent application in June 2026 covering the high-dimensional biological data structure underpinning HYFT Technology, and inclusion in the Russell 3000E and Russell Microcap Indexes effective after the U.S. market close on June 26, 2026, which broadens institutional visibility. MindWalk also noted that its discovery platform has contributed to more than 20 molecules reaching the clinic, supported by over 400 peer-reviewed publications and issued patents, though it characterized those as client-owned assets rather than its own pipeline.

Track the Trade With Quote Daddy 

Following an AI-and-biotech name like this one usually means fighting an app that barely keeps up. Quote Daddy handles NYSE and Nasdaq alongside TSX, TSX-V and CSE, with live watchlists, interactive charts, SEC filings and insider activity, price alerts, and portfolio tracking with live profit and loss. It is free, with no paywalls, on web and mobile. Build your first watchlist in under a minute at quotedaddy.com.

How MindWalk Sits Against the Field

MindWalk's recurring-revenue argument is easier to judge against peers that have already tried to turn software, data, or discovery platforms into durable revenue. Four public companies, at very different stages, illustrate the range of models in play.

Schrödinger (Nasdaq: SDGR)

Schrödinger is the clearest analogue to the model MindWalk is pursuing. It sells physics-based simulation software to pharmaceutical and biotech researchers as recurring, subscription-style revenue, while also building its own pipeline that can generate milestones and royalties. In other words, software revenue today, drug economics tomorrow. Schrödinger has one of the largest installed bases in computational chemistry and has guided to double-digit growth in annual contract value, and it is one of the few names in the space that has approached profitability. For MindWalk, Schrödinger is both a template and a benchmark: it shows that the recurring-software-plus-pipeline model can work, and it sets the bar for what that model looks like at scale.

AbCellera Biologics (Nasdaq: ABCL)

AbCellera Biologics runs an AI and machine-learning antibody-discovery platform, partnering with large pharmaceutical companies that bring targets while AbCellera runs the discovery and earns downstream as programs advance, alongside a growing proprietary pipeline. Its reported revenue grew sharply year over year in early 2026, and it holds a large liquidity position to fund its own programs. The parallel to MindWalk is direct on the science side, since MindWalk's own roots include B-cell and nanobody antibody work, and on the business side both are trying to balance partner-driven revenue with owned pipeline value. AbCellera's dual model, royalty-style partner economics plus proprietary assets, is a useful reference for how investors value that blend.

Relay Therapeutics (Nasdaq: RLAY)

Relay Therapeutics represents the platform-into-pipeline path taken further toward the clinic. Its Dynamo platform combines machine learning with physics-based simulation to target the motion of proteins, and the company has advanced its lead oncology candidate into late-stage development, earning an FDA Breakthrough Therapy designation along the way. Relay is a reminder that computational-discovery platforms are increasingly judged by clinical results, not just software metrics, and that raising capital to fund those trials, as Relay did in 2026, is part of the model. For MindWalk investors, Relay illustrates both the upside of a platform that produces a clinical asset and the capital intensity that comes with it.

Certara (Nasdaq: CERT)

Certara is the established, profitable end of the spectrum. It sells biosimulation and model-informed drug-development software and services to the pharmaceutical industry, generating recurring software revenue with healthy margins, and it has been reshaping its portfolio to focus on its core simulation platforms. Certara shows what a mature, recurring-revenue software business in drug development looks like once it has scaled, which is precisely the destination MindWalk is arguing it can grow toward. The contrast in size is large, but the business logic, durable software revenue anchored to the drug-development workflow, is the same one MindWalk is making to investors.

What to Watch From Here 

The fiscal 2026 report gives the recurring-revenue thesis its first real evidence: accelerating growth, expanding margins, a sharply narrower loss, and, most importantly, the first contracted recurring platform agreements. The near-term question is whether MindWalk can convert those first two LensAI contracts into a repeatable pattern, signing additional enterprise agreements that build a genuine recurring-revenue base rather than remaining one-off wins. Investors will also be watching the commercial traction of ReefIQ following its June launch, the pace of margin expansion, and any updates on the discovery programs the company has referenced.

None of this removes the risks. MindWalk is a small-cap company with a history of net losses, its results are preliminary pending the filing of its Form 20-F, and turning early recurring contracts into a durable business is far from guaranteed. But the setup is clearer than it was a year ago: a company that spent years building a platform is now, on its own numbers, beginning to sell it, and the market gets to judge that claim against real results rather than projections.

Contact:

USA News Group
[email protected]

Article Source:

MindWalk Holdings Corp., "MindWalk Holdings Corp. Reports Fiscal 2026 Results," press release, July 22, 2026. DISCLAIMER

Nothing in this publication should be considered personalized financial advice. We are not licensed under securities laws to address your particular financial situation, and no communication from us should be deemed personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor a recommendation to buy or sell any security. We hold no investment licenses and are neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances.

This article is being distributed by USA News Group, which is wholly owned and operated by Market Equities Limited ("MEL"). MEL has been paid a fee for MindWalk Holdings Corp. advertising and digital media from Creative Direct Marketing Group ("CDMG"). MEL also expects to receive further compensation as part of an ongoing digital media effort to increase visibility for the company. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged not to use this publication as the basis for any investment decision. The content in this article has been reviewed and approved on behalf of MindWalk Holdings Corp. by CDMG.

MEL and its owner/operators do not own any shares of MindWalk Holdings Corp., but reserve the right to buy and sell shares of MindWalk Holdings Corp. at any time without any further notice commencing immediately and ongoing, in the open market, through private placements, and/or through other investment vehicles. There may also be third parties who hold shares of MindWalk Holdings Corp. and may liquidate their shares, which could have a negative effect on the price of the stock.

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this publication is not trustworthy unless verified by their own independent research. Because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may lose some or all of your investment.

Financial figures on this page describing MindWalk Holdings Corp.'s fiscal 2026 results are drawn from the company's own earnings release and are preliminary results reported ahead of, and subject to, the filing of the company's Annual Report on Form 20-F; final audited figures may differ, and all amounts are in Canadian dollars unless otherwise noted. References to HYFT® Technology, ReefIQ™, and LensAI™, and to the company's platform, patents, publications, molecules, and pipeline, describe early-stage products and activities that have not been independently verified and may not translate into future commercial outcomes; ReefIQ™ registration is pending. HYFT® is a registered trademark, and LensAI™ and ReefIQ™ are trademarks, of MindWalk Holdings Corp. or its subsidiaries. Forward-looking statements involve known and unknown risks and uncertainties, including the company's history of net losses and its ability to convert engagement into contracted, recurring arrangements; readers should not place undue reliance on them.

References to Schrödinger, AbCellera Biologics, Relay Therapeutics, Certara, and any of their respective products, platforms, or programs are for comparative and illustrative context only. MindWalk Holdings Corp. is not a party to, and is not affiliated with, the products, platforms, or corporate activities of those companies, and their businesses are at different and generally more advanced stages. Each company carries its own independent risks and must be evaluated on its own merits.

Quote Daddy Disclosure.

Quote Daddy is a stock-tracking application affiliated with the publisher of this article, and this reference constitutes promotion of an affiliated product. Quote Daddy is not a broker-dealer, and nothing in the application or in this article is financial, investment, tax, or legal advice. Market data provided in the application is for informational purposes only and may be delayed. Any in-app commentary or briefing content is educational only. Always do your own research before making any investment decision.

SOURCE USA News Group